Indegene, a digital-first life sciences commercialization company, has introduced Cortex, a purpose-built Generative AI (GenAI) platform designed specifically for the life sciences industry. With its specialized knowledge engineering and multi-agent orchestration, Cortex enables life sciences leaders to harness and scale AI-driven transformation with enterprise-grade governance and reliability.
This groundbreaking platform plays a crucial role in streamlining high-value use cases such as optimizing the content supply chain, enhancing medical writing efficiency, and accelerating Medical-Legal-Regulatory (MLR) reviews. Cortex integrates Indegene’s 25+ years of domain expertise through advanced knowledge graphs, offering a user-friendly interface that simplifies complex processes. Unlike industry-agnostic AI solutions, Cortex is tailored to life sciences, ensuring greater accuracy, trustworthiness, and faster turnaround times.
One of its key advantages lies in its adaptability. The platform’s fit-for-purpose agents can integrate with any preferred Large Language Model (LLM) and evolve alongside AI advancements. Its multi-agent orchestration enables seamless enterprise-wide system integration, delivering measurable ROI with reduced risks. By embedding domain-specific knowledge graphs, Cortex continuously refines its understanding of life sciences workflows, driving better outcomes and efficiency.
Industry experts recognize Indegene’s pioneering role in leveraging GenAI for life sciences. HFS Research has named Indegene a Horizon 3 OneEcosystem Exponential Leader for its innovative collaborations across healthcare and life sciences. Additionally, Everest Group has acknowledged Indegene as a FrontRunner for its expertise in scaling GenAI, developing industry-specific solutions, and delivering tangible value.
